Moseley Investment Management Inc Bristol Myers Squibb CO Transaction History

Moseley Investment Management Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 16, 2024	BUY	$40.25 - $52.99 $40 - $52	1 Added 0.02%	5,515 $229,000
Q1 2024 Apr 04, 2024	BUY	$47.98 - $54.4 $264,561 - $299,961	5,514 New	5,514 $299,000
Q4 2021 Jan 25, 2022	SELL	$53.63 - $62.52 $181,269 - $211,317	-3,380 Closed	0 $0
Q3 2021 Oct 27, 2021	SELL	$59.17 - $69.31 $20,117 - $23,565	-340 Reduced 9.14%	3,380 $201,000
Q2 2021 Aug 11, 2021	BUY	$61.91 - $67.42 $24,764 - $26,968	400 Added 12.05%	3,720 $249,000
Q4 2020 Jan 26, 2021	BUY	$57.74 - $65.43 $191,696 - $217,227	3,320 New	3,320 $206,000
Q4 2019 Jan 15, 2020	SELL	$49.21 - $64.19 $260,813 - $340,207	-5,300 Closed	0 $0
Q3 2019 Oct 30, 2019	SELL	$42.77 - $50.71 $67,063 - $79,513	-1,568 Reduced 22.83%	5,300 $269,000
Q1 2019 May 09, 2019	BUY	$45.12 - $53.8 $309,884 - $369,498	6,868 New	6,868 $328,000

2,533

1.47B

31.6M

35M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $124B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Moseley Investment Management Inc, based on Form 13F filings with the SEC.

Stay updated on Moseley Investment Management Inc with notifications on news.